• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在自然主义初级保健环境中测量抑郁症状。

Measuring depressive symptoms in the naturalistic primary-care setting.

作者信息

McIntyre R S, Konarski J Z, Kennedy S H, Dickens S E, Bagby R M

机构信息

Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

出版信息

Int J Clin Pract. 2007 Aug;61(8):1278-82. doi: 10.1111/j.1742-1241.2007.01448.x. Epub 2007 Jun 22.

DOI:10.1111/j.1742-1241.2007.01448.x
PMID:17590219
Abstract

BACKGROUND

The majority of individuals with major depressive disorder are diagnosed and treated in the primary-care setting. A quantifiable critical objective in the management of depression is to achieve and sustain full symptomatic remission. The HAMD-7 is a depression metric validated in both tertiary and primary-care settings.

METHODS

Herein, we further characterise the psychometric properties of the HAMD-7 in depressed patients treated in primary-care settings. Several cut-scores were evaluated for maximum agreement; diagnostic efficacy statistics with the original HAMD-7 items were also evaluated. We compared performance of the HAMD-7 in primary care to a previously characterised tertiary sample.

RESULTS

The depressive symptoms most frequently endorsed (>or=70%) and most sensitive to change during antidepressant treatment in depressed primary-care patients were depressed mood, guilt, work and activities, psychic and somatic anxiety and fatigue.

LIMITATIONS

This is a post hoc analysis of a primary-care database; assumptions regarding the definition of symptomatic remission in depression affect interpretation.

CONCLUSION

Measurement-based care with the HAMD-7 quantifies the severity of commonly reported depressive items and their responsivity to treatment. The HAMD-7, inclusive of the suicide item, is capable of tracking symptom progress, with a validated remission cut-score.

摘要

背景

大多数重度抑郁症患者在初级保健机构接受诊断和治疗。抑郁症管理中的一个可量化的关键目标是实现并维持症状完全缓解。汉密尔顿抑郁量表-7(HAMD-7)是一种在三级医疗机构和初级保健机构均得到验证的抑郁评估指标。

方法

在此,我们进一步描述HAMD-7在初级保健机构治疗的抑郁症患者中的心理测量特性。评估了几个临界值以达到最大一致性;还评估了与原始HAMD-7项目相关的诊断效能统计数据。我们将HAMD-7在初级保健中的表现与之前描述的三级样本进行了比较。

结果

在初级保健抑郁症患者中,最常被认可(≥70%)且在抗抑郁治疗期间对变化最敏感的抑郁症状是情绪低落、内疚、工作和活动、精神和躯体焦虑以及疲劳。

局限性

这是对一个初级保健数据库的事后分析;关于抑郁症症状缓解定义的假设影响解释。

结论

基于HAMD-7的测量护理可量化常见抑郁项目的严重程度及其对治疗的反应性。包含自杀项目的HAMD-7能够追踪症状进展,并具有经过验证的缓解临界值。

相似文献

1
Measuring depressive symptoms in the naturalistic primary-care setting.在自然主义初级保健环境中测量抑郁症状。
Int J Clin Pract. 2007 Aug;61(8):1278-82. doi: 10.1111/j.1742-1241.2007.01448.x. Epub 2007 Jun 22.
2
Residual anxiety symptoms in depressed primary care patients.抑郁症初级护理患者的残余焦虑症状
J Psychiatr Pract. 2007 Mar;13(2):125-8. doi: 10.1097/01.pra.0000265772.26627.99.
3
Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.抗抑郁药引发的早期改善能否预测疗效/缓解情况?对大量重度抑郁症住院患者的自然主义研究数据进行分析。
J Affect Disord. 2009 Jun;115(3):439-49. doi: 10.1016/j.jad.2008.10.011. Epub 2008 Nov 22.
4
Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.抑郁症中的焦虑症状:汉密尔顿焦虑量表在抑郁症患者中的条目性能评估
Depress Anxiety. 2008;25(12):1006-13. doi: 10.1002/da.20435.
5
An Item Response analysis of the Hamilton Depression Rating Scale using shared data from two pharmaceutical companies.利用两家制药公司的共享数据对汉密尔顿抑郁量表进行项目反应分析。
J Psychiatr Res. 2004 May-Jun;38(3):275-84. doi: 10.1016/j.jpsychires.2003.11.003.
6
Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.度洛西汀治疗的轻度、中度或更严重抑郁症门诊患者的抑郁症状反应模式。
Int J Clin Pract. 2007 Aug;61(8):1337-48. doi: 10.1111/j.1742-1241.2007.01444.x.
7
Improving outcomes in depression: a focus on somatic symptoms.改善抑郁症的治疗效果:关注躯体症状。
J Psychosom Res. 2006 Mar;60(3):279-82. doi: 10.1016/j.jpsychores.2005.09.010.
8
Objective: remission of depression in primary care The Oreon Study.目的:初级保健中抑郁症的缓解——奥雷翁研究
Eur Neuropsychopharmacol. 2009 Mar;19(3):169-76. doi: 10.1016/j.euroneuro.2008.10.003. Epub 2009 Jan 13.
9
Treatment of depressive disorders with and without medication - a naturalistic study.使用和不使用药物治疗抑郁症——一项自然主义研究。
Pharmacopsychiatry. 2002 Nov;35(6):235-8. doi: 10.1055/s-2002-36387.
10
Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.抗抑郁药反应的时间进程:早期改善的预测价值及附加心理治疗的效果
J Affect Disord. 2009 Apr;114(1-3):243-53. doi: 10.1016/j.jad.2008.07.023. Epub 2008 Oct 11.

引用本文的文献

1
Association between AKT1 gene polymorphisms and depressive symptoms in the Chinese Han population with major depressive disorder.AKT1 基因多态性与汉族抑郁症患者抑郁症状的关联。
Neural Regen Res. 2012 Jan 25;7(3):235-9. doi: 10.3969/j.issn.1673-5374.2012.03.014.